GeneDx (WGS) Stock: Buy, Sell, or Hold?
WGS - GeneDx Holdings Corp. Class A Common Stock
$74.59
3.63 (5.12%)
▲
5d:
-15.62%
30d:
-13.99%
90d:
+8.27%
HOLD
MODERATE Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 27, 2026
24d
Get Alerted When WGS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: WGS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: WGS shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$58.35
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$36.23
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: WGS is currently trading at $74.59, which is considered oversold relative to its 30-day fair value range of $82.98 to $94.61. From a valuation perspective, the stock is trading at a discount (Forward PE: 59.2) compared to its historical average (102.9). Remarkably, the market is currently pricing in an annual earnings decline of 16.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, WGS is in a strong uptrend. Immediate support is located at $70.69, while resistance sits at $105.00. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: WGS scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $92.38 (+30.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, WGS is in a strong uptrend. Immediate support is located at $70.69, while resistance sits at $105.00. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: WGS scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $92.38 (+30.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$82.98 -
$94.61
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
Protect Your Profits
Holding WGS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (39/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.1%)
- BULLISH: Trading 30.2% below Wall St target ($92.38)
- CAUTION: 5-day price weakness (-15.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$82.98 -
$94.61
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$70.69
Resistance Level
$105.00
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
59.20
Wall Street Target
$92.38
(+30.2%)
Revenue Growth (YoY)
11.4%
Profit Margin
-23.4%
Valuation Discount vs History
-16.8% cheaper
PE vs Historical
59.2 vs 102.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.8%
(market-implied from PE analysis)
1-Year Target
$63.86
(-10%)
2-Year Target
$57.48
(-19%)
3-Year Target
$51.73
(-27%)
3-Yr Target (if PE normalizes)
(PE: 59→103)
$89.91
(+27%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 59.2, Growth: 812.2%)
$239.49
(+238%)
Base:
(SPY PE: 20.4, Growth: 812.2%)
$82.52
(+16%)
Bear:
(PE: 17.3, Growth: 812.2%)
$70.15
(-1%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 59.2 to 102.9
Stabilization Target:
$123.34
(+73.8%)
PE Expansion Potential:
+73.8%
Share & Embed Analysis
Last updated: October 02, 2026 9:59 AM ET
Data refreshes hourly during market hours. Next update: 10:59 AM
Data refreshes hourly during market hours. Next update: 10:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WGS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$653 | 43 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 48 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 46 HOLD |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$345 | 65 BUY |
Advanced WGS Option Strategies
Professional options setups generated by AI based on today's WGS price and gamma walls.
